About Joris

Joris Kleintjens has more than 15 years of expertise in health economics, healthcare policy, and market access for biopharmaceuticals and medical devices. He developed various types of economic models, such as late- and early-stage cost-effectiveness models, budget impact models, and payer value tools.

His consulting experience spans both health economics and related fields, such as healthcare policy, market access strategy, and outcomes research. He gained experience across the full product life-cycle and in various disease areas, including oncology, cardiovascular, infectious, central nervous-system, and rare diseases.

Prior to Precision, Joris worked internationally at various other consulting companies and started his career in regulatory affairs at a biopharmaceutical company.

EDUCATION:
MSc, Health Economics, Policy and Law
MSc, Molecular Biology